Skip to content
healthcare.dev

Duloxetine

NDC 87063-702, Duloxetine, capsule, delayed release, from ASCLEMED USA INC..

Product NDC
87063-702
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208706
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DULOXETINE HYDROCHLORIDE20 mg/1

Pharmacologic classes

Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
87063-702-1287063070212120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (87063-702-12)
87063-702-308706307023030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (87063-702-30)
87063-702-608706307026060 CAPSULE, DELAYED RELEASE in 1 BOTTLE (87063-702-60)
87063-702-908706307029090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (87063-702-90)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87063-702 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.